Search Results 1121-1130 of 17072 for monoclonal antibody
... antibody), or other stable chronic liver disease are acceptable ... Receipt of any marketed or investigational biologic (monoclonal or polyclonal antibody) ...
LGI1 antibody encephalitis: acute treatment comparisons and outcome. ... Autoimmune/Paraneoplastic Encephalitis Antibody ... monoclonal protein-skin changes and ...
History of severe hypersensitivity reactions to any ingredient of study drug(s) (azacitidine, venetoclax or MGB453) or monoclonal antibodies (mAbs) and/or their ...
Routine IHC/IF. Automated immunostaining is performed using a variety of antibody detection chemistries, including diaminobenzidine (DAB) and alkaline ...
... monoclonal antibodies, including therapeutic antibodies. Patients with the following infectious diseases are excluded: known HIV;; active Hepatitis B ...
Treatment with an investigational drug or device within 30 days of study entry or any prior exposure to a monoclonal antibody targeting the CGRP pathway.
Participants also must have prior exposure to an anti-CD20 monoclonal antibody. Tumor must be cluster of differentiation (CD) 20 positive; Measurable disease ...
... antibody. - Refractory to, or had documented ... * Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, and Skin changes (POEMS) Syndrome * ...
Patients who have had a prior monoclonal antibody within 4 weeks prior to study day 1 are not eligible. Patients with a known additional malignancy that is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.